NeoGenomics' new facility is expected to open in 2021.
FORT MYERS — NeoGenomics Inc., a provider of cancer-focused genetic testing services, has announced it intends to build a cancer diagnostics testing facility and new global business headquarters in Fort Myers.
The new facility will be on a 14-acre parcel near the intersection of Alico Road and Three Oaks Parkway, according to a press release. It is expected to open in 2021.
The site is a short drive from the existing NeoGenomics footprint in Fort Myers and remains in the vicinity of the Southwest Florida International Airport, the statement adds.
The 150,000-square-foot laboratory and headquarters facility will incorporate technology to deliver oncology testing for physicians and their patients. The lab will also support clinical trials for new oncology therapeutics.
The Florida Department of Economic Opportunity and Lee County have agreed to support NeoGenomics' expansion to encourage the company's growth of high-paying jobs in a "high-impact sector" of the local economy, the release adds.
"As a leading provider of cancer testing in the United States, NeoGenomics is deeply committed to deploying advanced diagnostic technologies to improve the quality of oncology care," says NeoGenomics Chairman and CEO Douglas VanOort in the statement. "We are grateful to the State of Florida for their tremendous support as we build a new state-of-the-art laboratory and headquarters facility, add new jobs and serve patients, physicians, health care organizations and our communities in an even bigger way as we continue to grow in the future."